Evidence map›Paper›PMID 34064609›Full record

ArticleInternational journal of molecular sciences2021

Factors Associated with Mutations: Their Matching Rates to Cardiovascular and Neurological Diseases.

Hannah B Lucas, Ian McKnight, Regan Raines, Abdullah Hijazi, Christoph Hart, Chan Lee, Do-Gyoon Kim, Wei Li, Peter H U Lee, Joon W Shim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Frontiers in genetics · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Hannah B LucasDepartment of Biomedical Engineering, College of Engineering and Computer Sciences, Marshall University, Huntington, WV 25755, USA.
Ian McKnightDepartment of Biomedical Engineering, College of Engineering and Computer Sciences, Marshall University, Huntington, WV 25755, USA.
Regan RainesDepartment of Biomedical Engineering, College of Engineering and Computer Sciences, Marshall University, Huntington, WV 25755, USA.
Abdullah HijaziDepartment of Biomedical Engineering, College of Engineering and Computer Sciences, Marshall University, Huntington, WV 25755, USA.
Christoph HartDepartment of Biomedical Engineering, College of Engineering and Computer Sciences, Marshall University, Huntington, WV 25755, USA.
Chan LeeIndiana University Health Arnett Hospital, Lafayette, IN 47905, USA.
Do-Gyoon KimDivision of Orthodontics, College of Dentistry, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0001-7673-1254
Wei LiDepartment of Biomedical Sciences, Joan C. Edwards School of Medicine of Marshall University, Huntington, WV 25755, USA.ORCID 0000-0002-7973-6242
Peter H U LeeDepartment of Cardiothoracic Surgery, Southcoast Health, Fall River, MA 02720, USA.
Joon W ShimDepartment of Biomedical Engineering, College of Engineering and Computer Sciences, Marshall University, Huntington, WV 25755, USA.
Marshall University · USBrown University · USIndiana University Health · USThe Ohio State University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI JUDITH FEINBERG · 2012 to 2026
$81.0M
WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI Travis Salisbury · 2012 to 2026
$61.1M
Regulation of Tight Junction Molecular Composition by Na/K-ATPaseP20GM121299 · NIGMS · MARSHALL UNIVERSITY · PI HAYNES, JENNIFER · 2018 to 2022
$10.6M
Thymidine Phosphorylase: a Novel Target of Antiplatelet TherapyR15HL145573 · NHLBI · MARSHALL UNIVERSITY · PI LI, WEI · 2019 to 2022
$878k
NHLBI NIH HHS R15 HL145573NIGMS NIH HHS P20 GM103434NIGMS NIH HHS U54 GM104942NIH HHS NIH P20GM103434NIH HHS P20GM121299
6 · The paper itself

Abstract

Monogenic hypertension is rare and caused by genetic mutations, but whether factors associated with mutations are disease-specific remains uncertain. Given two factors associated with high mutation rates, we tested how many previously known genes match with (i) proximity to telomeres or (ii) high adenine and thymine content in cardiovascular diseases (CVDs) related to vascular stiffening. We extracted genomic information using a genome data viewer. In human chromosomes, 64 of 79 genetic loci involving >25 rare mutations and single nucleotide polymorphisms satisfied (i) or (ii), resulting in an 81% matching rate. However, this high matching rate was no longer observed as we checked the two factors in genes associated with essential hypertension (EH), thoracic aortic aneurysm (TAA), and congenital heart disease (CHD), resulting in matching rates of 53%, 70%, and 75%, respectively. A matching of telomere proximity or high adenine and thymine content projects the list of loci involving rare mutations of monogenic hypertension better than those of other CVDs, likely due to adoption of rigorous criteria for true-positive signals. Our data suggest that the factor-disease matching rate is an accurate tool that can explain deleterious mutations of monogenic hypertension at a >80% match-unlike the relatively lower matching rates found in human genes of EH, TAA, CHD, and familial Parkinson's disease.

Indexed as

Genetic Predisposition to DiseaseMutationPolymorphism, Single NucleotideAdenineCardiovascular DiseasesHumansNervous System DiseasesTelomereThymineAdenineThymineadenine thymine contentcongenital heart diseasehypertensionParkinson’s diseasesingle nucleotide polymorphism (SNP)telomerethoracic aortic aneurysm

Identifiers

PMID34064609
PMCPMC8151074
OpenAlexW3162895470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.